ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

Called “Unscrupulous” in Abramson Lawsuit, Thompson Calls Abramson A Rich Man Scorned

March 23, 2012

Senate Kills Plan to Increase Tax On Higher Tar, Nicotine Cigarettes

August 13, 1976

Clinical Trials Approved By NCI Last Month Are Listed

April 25, 2003

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

April 11, 2008

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

New Algorithm Completes Scan Three Times Faster Than Before

November 25, 2011